期刊文献+

高血压和心房颤动相互作用机制以及动态血压监测意义的探讨

The interaction mechanism between hypertension and atrial fibrillation and the significance of ambulatory blood pressure monitoring
下载PDF
导出
摘要 高血压和心房颤动是临床上常见的两种心血管疾病,近年来呈现高发趋势,且两者相互作用、相互影响,形成恶性循环,因此对其发病机制的研究显得尤为重要。动态血压监测能够更显著地反映出高血压合并心房颤动患者全天的血压变化情况和平均血压水平,能够及时有效地发现疾病,对提高患者的预后有很大的帮助。本文总结了高血压合并心房颤动的相互作用机制以及动态血压监测在临床中对疾病诊断的重要性。 Hypertension and atrial fibrillation are two common cardiovascular diseases in clinic,with a high incidence in recent years.They interact and influence each other to form a vicious circle,so it is particularly important to study their pathogenesis.Ambulatory blood pressure monitoring can significantly reflect the blood pressure changes and average blood pressure levels of patients with hypertension complicated with atrial fibrillation throughout the day,so as to detect diseases timely and effectively,which is of great help to improve the prognosis of patients.This paper summarizes the interaction mechanism of hypertension complicated with atrial fibrillation and the importance of ambulatory blood pressure monitoring in clinical diagnosis.
作者 司雅静 牟艳鹏 胡安印 孟亮 SI Yajing;MOU Yanpeng;HU Anyin;MENG Liang(Shenyang Medical College,Shenyang 110034,China;Department of Cardiology,The Central Hospital Affiliated to Shenyang Medical College)
出处 《沈阳医学院学报》 2021年第6期613-616,共4页 Journal of Shenyang Medical College
关键词 高血压 心房颤动 相互作用 动态血压监测 hypertension atrial fibrillation interaction ambulatory blood pressure monitoring
  • 相关文献

参考文献14

二级参考文献87

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 2陈样新,傅国胜,江建军,唐礼江,方崇峰.心房颤动患者Korotkoff音法测压与动脉有创测压之间的比较[J].临床心血管病杂志,2005,21(9):530-531. 被引量:6
  • 3胡大一,孙艺红.心房颤动的流行病学和治疗现状[J].中华全科医师杂志,2006,5(1):5-7. 被引量:85
  • 4龚艳君,丁文惠,丁燕生,杨玲,吴建芳.1335例心房颤动住院患者病因(或相关因素)分析[J].中华老年心脑血管病杂志,2006,8(10):658-661. 被引量:17
  • 5Wong ND, Lopez VA, Lltalien G. Inadequate control of hypertension in US a- dults with cardiovascular disease comorbidities in 2003-2004 [ J ]. Arch Intern Med, 2007, 167(22) :2431-2436.
  • 6le Heuzey JY, Breithardt G, Carom J. The RecordAF study : design, baseline data, and profile of patients according to chosen treatment strategy for atrial fi- briUation[J]. Am J Cardiol, 2010, 105(5) :687-693.
  • 7Hohnloser SH, Crijns HI, van Eickels M. Effect of dronedarone on cardiovascu- lar events in atrial fibrillation[J]. N Engl J Med, 2009,360(7) :668-678.
  • 8Yusuf S. A randomized evaluation of irbesartan versus placebo in patients with atrial fibrillation (factorial design of ACTIVE Program) [ J ]. ESC 2009 Hofline Session No. 3586-3587.
  • 9Connolly SJ, Ezekowitz MD, Yusuf S. Dabigatran versus warfarin in patients with atrial fibrillation[J]. N Engl J Med, 2009, 361 (12) :1139-1151.
  • 10Patel MR, Mahaffey KW, Garg J. Rivaroxaban versus warfarin in nonvalvular at- rial fibrillation[ J ]. N Engl J Med, 2011, 365 (10) :883-891.

共引文献243

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部